Home 禄 Business 禄 Manufacturing
Listing on schedule
By Ding Yining |
May 19, 2011, Thursday
|
Print Edition
Print Edition
SHANGHAI Pharmaceuticals Holding Co yesterday said its listing on the Hong Kong stock exchange tomorrow will go on as scheduled although Anhui Huayuan Pharmaceutical filed a complaint about alleged malpractices of Shanghai Pharma's subsidiaries.
Huayuan Pharma, a distributor of Shanghai Asia Pioneer Pharmaceutical and Shanghai Huakang Pharmaceutical, alleged that their products have serious quality problems.
The two units are set to be injected into listed Shanghai Pharma once they have fulfilled requirements.
"Transactions of these two units have not been completed yet, and they do not belong to the assets of the listed company," said Xu Guoxiong, president of Shanghai Pharmaceutical Group, the parent of Shanghai Pharma.
Huayuan Pharma, a distributor of Shanghai Asia Pioneer Pharmaceutical and Shanghai Huakang Pharmaceutical, alleged that their products have serious quality problems.
The two units are set to be injected into listed Shanghai Pharma once they have fulfilled requirements.
"Transactions of these two units have not been completed yet, and they do not belong to the assets of the listed company," said Xu Guoxiong, president of Shanghai Pharmaceutical Group, the parent of Shanghai Pharma.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
